LeonaBio, Inc.
LONAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How LeonaBio, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Sep 30, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 2025-09-30 | 1,000 | Not shown | SEC filing |
| Global Retirement Partners, LLC | 2025-09-30 | 52 | Not shown | SEC filing |
| Royal Bank of Canada | 2025-06-30 | 27,156 | Not shown | SEC filing |
| American Capital Advisory, LLC | 2025-06-30 | 2,000 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2025-06-30 | 63,500 | Not shown | SEC filing |
| McIlrath & Eck, LLC | 2025-06-30 | 825 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2025-06-30 | 241,000 | Not shown | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2025-06-30 | 1,500 | Not shown | SEC filing |
| Pathstone Holdings, LLC | 2025-06-30 | 372,196 | Not shown | SEC filing |
| Propel Bio Management, LLC | 2025-06-30 | 1,492,792 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2025-06-30 | 1,399 | Not shown | SEC filing |
| Invst, LLC | 2025-06-30 | 45,000 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2025-06-30 | 143 | Not shown | SEC filing |
| UBS Group AG | 2025-06-30 | 203,475 | Not shown | SEC filing |
| Laird Norton Wetherby Trust Company, LLC | 2025-06-30 | 127,309 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2025-06-30 | 80,524 | Not shown | SEC filing |
| BML Capital Management, LLC | 2025-06-30 | 3,230,667 | Not shown | SEC filing |
| US BANCORP \DE\ | 2025-06-30 | 815 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2025-06-30 | 305,964 | Not shown | SEC filing |
| PERCEPTIVE ADVISORS LLC | 2025-06-30 | 5,402,964 | Not shown | SEC filing |
- Each value is checked against LeonaBio, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Global Retirement Partners, LLC: 519 shares reported 2025-06-30; 52 shares reported 2025-09-30.
- VANGUARD GROUP INC: 1,537,914 shares reported 2025-03-31; 1,537,914 shares reported 2025-06-30.
- JOURNEY STRATEGIC WEALTH LLC: 20,538 shares reported 2025-03-31; 20,538 shares reported 2025-06-30.
- BLAIR WILLIAM & CO/IL: 20,000 shares reported 2025-03-31; 20,000 shares reported 2025-06-30.
- CITADEL ADVISORS LLC: 49,573 shares reported 2025-03-31; 210,128 shares reported 2025-06-30.
- HRT FINANCIAL LP: 14,077 shares reported 2025-03-31; 16,156 shares reported 2025-06-30.
- Qube Research & Technologies Ltd: 221,068 shares reported 2025-03-31; 192,684 shares reported 2025-06-30.
- XTX Topco Ltd: 46,148 shares reported 2025-03-31; 52,986 shares reported 2025-06-30.
- Clarius Group, LLC: 53,551 shares reported 2025-03-31; 53,551 shares reported 2025-06-30.
- Integrity Financial Corp /WA: 52,902 shares reported 2025-03-31; 52,902 shares reported 2025-06-30.
- STATE STREET CORP: 107,381 shares reported 2025-03-31; 107,381 shares reported 2025-06-30.
- Engineers Gate Manager LP: 11,042 shares reported 2025-03-31; 11,042 shares reported 2025-06-30.
Showing the 12 most recent filer reports.
13 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among LeonaBio, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2023-12-28 · EDELMAN JOSEPH: Larger than 21 of the 22 other insider purchases of Common Stock on file. SEC filing
- 2022-06-30 · EDELMAN JOSEPH: Larger than all 22 other insider purchases of Common Stock on file. SEC filing
- 2022-06-29 · EDELMAN JOSEPH: Larger than 20 of the 22 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2023-03-29–2023-03-30: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-06-28–2022-06-30: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-04 | San Martin Javier · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −1,720 | 5.37 | SEC filing |
| 2026-03-04 | Worthington Mark · GENERAL COUNSEL and CCO | Common Stock | S — Open market or private sale | −1,328 | 5.37 | SEC filing |
| 2026-03-04 | Litton Mark James · PRESIDENT and CEO | Common Stock | S — Open market or private sale | −5,156 | 5.37 | SEC filing |
| 2026-03-04 | CHURCH KEVIN · CHIEF SCIENTIFIC OFFICER | Common Stock | S — Open market or private sale | −1,359 | 5.37 | SEC filing |
| 2026-03-04 | Renninger Robert · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −906 | 5.37 | SEC filing |
| 2026-01-02 | San Martin Javier · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −1,644 | 6.88 | SEC filing |
| 2026-01-02 | Renninger Robert · Chief Financial Officer | Common Stock | S — Open market or private sale | −297 | 6.88 | SEC filing |
| 2026-01-02 | CHURCH KEVIN · CHIEF SCIENTIFIC OFFICER | Common Stock | S — Open market or private sale | −876 | 6.88 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-23 | Callori Fred · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +2,333 | SEC filing |
| 2026-06-23 | Panzara Michael A. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-23 | Holles Natalie C. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +2,333 | SEC filing |
| 2026-06-23 | EDELMAN JOSEPH · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-23 | PICKERING GRANT · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-23 | Romano Kelly A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-23 | JOHNSON JAMES A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +28,000 | SEC filing |
| 2026-06-23 | Silverman Peter B. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +2,333 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.